ProQR Announces Results for the Third Quarter of 2016 Press release LEIDEN, the Netherlands, Nov. 14, 2016 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. November 14, 2016
ProQR to Present at Three Scientific Conferences in April Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., April 22, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. April 22, 2019
ProQR to Present at the JMP Life Sciences Conference Press release LEIDEN, the Netherlands, June 14, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. June 14, 2018
ProQR to Present at the Chardan Genetic Medicines Conference Press release LEIDEN, the Netherlands, Oct. 02, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. October 02, 2018
ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., March 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. March 31, 2021
ProQR Prices $90.6 Million Underwritten Public Offering of Ordinary Shares Press release LEIDEN, Netherlands and CAMBRIDGE, Mass., Sept. 07, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. September 07, 2018
ProQR Announces R&D Day and Provides Update on Innovation Portfolio Press release First Investor R&D Day on March 14, 2016 in New York, NY November 30, 2015
ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares Press release LEIDEN, The Netherlands and CAMBRIDGE, Mass., Oct. 15, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. October 16, 2019
ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer Press release Proven leader with deep worldwide ophthalmology experience, including multiple approvals globally October 05, 2020
